242 related articles for article (PubMed ID: 4128128)
1. In vivo and in vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis.
Webb C; Teitelbaum D; Arnon R; Sela M
Eur J Immunol; 1973 May; 3(5):279-86. PubMed ID: 4128128
[No Abstract] [Full Text] [Related]
2. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis.
Falk GA; Kies MW; Alvord EC
J Immunol; 1968 Oct; 101(4):638-44. PubMed ID: 4971475
[No Abstract] [Full Text] [Related]
3. Cell-mediated vs humoral response in the cross-reaction between hen egg-white lysozyme and bovine -lactalbumin.
Maron E; Webb C; Teitelbaum D; Arnon R
Eur J Immunol; 1972 Jun; 2(3):294-7. PubMed ID: 4652874
[No Abstract] [Full Text] [Related]
4. Experimental allergic encephalomyelitis in resistant and susceptible guinea pigs: in vivo and in vitro correlates.
Lisak RP; Zweiman B; Kies MW; Driscoll B
J Immunol; 1975 Feb; 114(2 Pt 1):546-9. PubMed ID: 47353
[TBL] [Abstract][Full Text] [Related]
5. Morphologic changes in draining lymph nodes and in lymphocyte cultures after sensitization with complete or incomplete Freund's adjuvant. Correlation with immunologic events in vivo and in culture.
Dvorak AM; Bast RC; Dvorak HF
J Immunol; 1971 Aug; 107(2):422-35. PubMed ID: 5568772
[No Abstract] [Full Text] [Related]
6. Cellular and humoral immune responses in guinea pigs and rabbits to chemically defined synthetic peptides.
Kelly B; Levy JG; Hull D
Eur J Immunol; 1973 Sep; 3(9):574-9. PubMed ID: 4766957
[No Abstract] [Full Text] [Related]
7. Activation of effector cells in experimental allergic encephalomyelitis by interleukin 2 (IL-2).
Ortiz-Ortiz L; Weigle WO
J Immunol; 1982 Apr; 128(4):1545-50. PubMed ID: 6174605
[No Abstract] [Full Text] [Related]
8. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
Raziuddin S; Kibler RF; Morrison DC
J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
[TBL] [Abstract][Full Text] [Related]
9. Transformation of lymphocytes from animals sensitized to Trichinella spiralis.
Kim CW; Jamuar MP; Hamilton LD
J Immunol; 1971 Nov; 107(5):1382-9. PubMed ID: 4256095
[No Abstract] [Full Text] [Related]
10. Experimental delayed type allergy without demonstrable antibodies. II. In vitro activity of reticulo-endothelial cells.
Holtzer JD
Immunology; 1967 Jun; 12(6):713-23. PubMed ID: 6027425
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immunity to myelin basic protein in Lewis rats made unresponsive to experimental allergic encephalomyelitis.
McGraw TP; Swanborg RH
Eur J Immunol; 1978 Dec; 8(12):905-9. PubMed ID: 365547
[TBL] [Abstract][Full Text] [Related]
12. Reaginic antibody in experimental allergic encephalomyelitis. I. Characterization of heat-labile skin-fixing antibody.
Moore MJ; Behan PO; Kies MW; Matthews JM
Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):119-32. PubMed ID: 4140559
[No Abstract] [Full Text] [Related]
13. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
[TBL] [Abstract][Full Text] [Related]
14. Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen.
Teitelbaum D; Webb C; Meshorer A; Arnon R; Sela M
Eur J Immunol; 1973 May; 3(5):273-9. PubMed ID: 4128127
[No Abstract] [Full Text] [Related]
15. Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody.
Akiyama K; Murakami T; Nomaguchi TA; Nagai Y
Jpn J Exp Med; 1981 Apr; 51(2):137-9. PubMed ID: 6168789
[No Abstract] [Full Text] [Related]
16. The application of the irradiated hamster test to the study of experimental allergic encephalomyelitis.
Kornblum J
J Immunol; 1968 Oct; 101(4):702-10. PubMed ID: 5681650
[No Abstract] [Full Text] [Related]
17. In vivo immunomodulation by monoclonal anti-CD4 antibody. II. Effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis.
Sriram S; Carroll L; Fortin S; Cooper S; Ranges G
J Immunol; 1988 Jul; 141(2):464-8. PubMed ID: 2454992
[TBL] [Abstract][Full Text] [Related]
18. Relationships between antibodies and experimental allergic encephalomyelitis. II. Identification and separation of species-specific non-encephalitogenic contaminants of encephalitogenic basic proteins.
Hruby S; Shaw CM; Alvord EC; August CS; Kies MW
Int Arch Allergy Appl Immunol; 1970; 37(5):532-45. PubMed ID: 5410778
[No Abstract] [Full Text] [Related]
19. Significance of the quantitative relationships of antigen and adjuvant for the efficiency of the adjuvant.
Tanaka A
Int Arch Allergy Appl Immunol; 1969; 36():Suppl:310-27. PubMed ID: 4984657
[No Abstract] [Full Text] [Related]
20. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
Holda JH; Silberg D; Swanborg RH
J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
